Preprint / Version 1

Cancer Uncovered: Genes, Tumors, and New Therapies

##article.authors##

  • Anirudh Dinesh Student

DOI:

https://doi.org/10.58445/rars.2777

Keywords:

Cancer, Genetic mutations, Tumors

Abstract

According to the World Health Organization, cancer is a leading cause of death, with an estimated 10 million deaths a year. Cancer relies on two factors: genetic and epigenetic changes that disrupt normal cellular functions. Even with years of doubts and research about what fuels tumor progression, many doubts regarding tumor heterogeneity, immune evasion, and the surrounding tumor microenvironment are unanswered. New genomic sequencing has uncovered how complex cancer can be, leading to both hope and debate on the most efficient ways to treat and prevent it. This paper focuses on the molecular and genetic basis of cancer, including findings and debates, from the classic oncogenes and tumor suppressor genes to the complex signaling pathways controlling cell behavior. Using recent research, this paper highlights the new opportunities for therapeutic innovation while emphasizing the many ways this disease affects the body.

References

Chang, Chih-Hao, et al. “Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.” Cell, vol. 162, no. 6, Elsevier BV, Sept. 2015, pp. 1229–41, https://doi.org/10.1016/j.cell.2015.08.016. Accessed 12 Feb. 2025.

Choi, Ha Yeong, and Ji-Eun Chang. “Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.” International Journal of Molecular Sciences, vol. 24, no. 17, Multidisciplinary Digital Publishing Institute, Sept. 2023, pp. 13618–18, https://doi.org/10.3390/ijms241713618. Accessed 27 Feb. 2025.

Cooper, Geoffrey M. “The Development and Causes of Cancer.” Nih.gov, Sinauer Associates, 2025, www.ncbi.nlm.nih.gov/books/NBK9963/. Accessed 27 Feb. 2025.

Dakal, Tikam Chand, et al. “Oncogenes and Tumor Suppressor Genes: Functions and Roles in Cancers.” MedComm, vol. 5, no. 6, Wiley, May 2024, https://doi.org/10.1002/mco2.582. Accessed 27 Feb. 2025.

Fotsitzoudis, Charalampos, et al. “Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—a Glance on Colorectal Cancer.” Cancers, vol. 14, no. 18, MDPI AG, Sept. 2022, p. 4394, https://doi.org/10.3390/cancers14184394. Accessed 27 Feb. 2025.

Huarte, Maite. “The Emerging Role of LncRNAs in Cancer.” Nature Medicine, vol. 21, no. 11, Springer Science and Business Media LLC, Nov. 2015, pp. 1253–61, https://doi.org/10.1038/nm.3981. Accessed 12 Feb. 2025.

Knudson, Alfred G. “Mutation and Cancer: Statistical Study of Retinoblastoma.” Proceedings of the National Academy of Sciences, vol. 68, no. 4, Proceedings of the National Academy of Sciences, Apr. 1971, pp. 820–23, https://doi.org/10.1073/pnas.68.4.820. Accessed 12 Feb. 2025.

Koya, Abdulmalik Idris, and Sherif A. Ibrahim. “Carcinogenesis.” Nih.gov, StatPearls Publishing, 2 Oct. 2024, www.ncbi.nlm.nih.gov/books/NBK604463/. Accessed 9 July 2025.

Krzyszczyk, Paulina, et al. “The Growing Role of Precision and Personalized Medicine for Cancer Treatment.” Deleted Journal, vol. 06, no. 03n04, Sept. 2018, pp. 79–100, https://doi.org/10.1142/s2339547818300020. Accessed 27 Feb. 2025.

Mardis, Elaine R. “The Impact of Next-Generation Sequencing on Cancer Genomics: From Discovery to Clinic.” Cold Spring Harbor Perspectives in Medicine, vol. 9, no. 9, Cold Spring Harbor Laboratory, Nov. 2018, p. a036269, https://doi.org/10.1101/cshperspect.a036269. Accessed 27 Feb. 2025.

Nandibala Devi Shamjetsabam, et al. “CRISPR/Cas9: An Overview of Recent Developments and Applications in Cancer Research.” International Journal of Surgery, vol. 110, no. 10, Wolters Kluwer, Feb. 2024, pp. 6198–213, https://doi.org/10.1097/js9.0000000000001081. Accessed 12 Feb. 2025.

Peer, Dan, et al. “Nanocarriers as an Emerging Platform for Cancer Therapy.” Nature Nanotechnology, vol. 2, no. 12, Nature Portfolio, Dec. 2007, pp. 751–60, https://doi.org/10.1038/nnano.2007.387. Accessed 12 Feb. 2025.

Posted

2025-07-20